corporate_fare

Chemo Research S.L.

Address: 3rd Floor, Calle De Manuel Pombo Angulo 28

Sponsor Overview

assignment

Specializations

Hemolytic Uremic Syndrome and Shiga toxin-producing Escherichia coli infection

Clinical research includes pediatric Hemolytic Uremic Syndrome linked to Shiga toxin-producing Escherichia coli, with attention to renal involvement and antitoxin-based treatment.

Kidney injury
Pediatric nephrology
Enteric bacterial toxins

The sponsor’s therapeutic interest in this area centers on severe toxin-mediated disease affecting the kidneys in children.

Contraception and pregnancy prevention

Several studies focus on oral contraception and vaginal delivery systems, including levonorgestrel-based approaches and comparison with established hormonal methods.

Contraceptive efficacy
Safety and tolerability
Hormonal contraception

Research activity in this domain also includes bioequivalence and drug-drug interaction questions relevant to contraceptive use in women.

Bone health in women using hormonal contraception

Trials examine the effect of contraceptive options on bone mineral density, with particular attention to the lumbar spine in adolescent and adult women.

Bone mineral density
Lumbar spine
Adolescent and adult female health

This area reflects interest in reproductive health alongside skeletal safety considerations during hormonal contraceptive use.

Pharmacokinetics and drug interactions in female health

Research includes pharmacokinetic evaluation of testosterone gel formulations and interaction studies involving miconazole, tampons, and lubricants with contraceptive products.

Drug-drug interactions
Female pharmacology
Bioequivalence

These studies support interest in how locally and systemically used products behave in healthy female participants.

Sponsored Trials

Trial Name	Country	Status
A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 13 cycles.	Czechia Germany Hungary Lithuania Poland Romania Slovakia Spain	Not Recruiting
A Phase 1, Randomized, Open-label Study to Evaluate the Pharmacokinetics and Bioequivalence of a Levonorgestrel Vaginal Delivery System in Healthy Female Volunteers	Spain	Recruiting
A pivotal, multicentre, randomised, open-label, parallel-group trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 9 cycles in comparison with Desogestrel tablets 0.075 mg.	Czechia Germany Hungary Lithuania Poland Romania Slovakia Spain	Not Recruiting
Efficacy Evaluation of Equine Immunoglobulin F(ab')2 Fragments Targeting Shiga Toxin in Pediatric Hemolytic Uremic Syndrome Induced by Shiga Toxin-Producing E. coli	Belgium France Germany Ireland Italy Romania Spain The Netherlands	Recruiting
Evaluation of Contraceptive Efficacy, Safety and Tolerability of Oral Drospirenone 4 mg (LPRI‑CF113) Over 13 Cycles: Multicentre Open‑Label Single‑Arm Study	Czechia Finland Hungary Poland Romania Spain Sweden	Not Yet Recruiting
Evaluation of Pharmacokinetic Interactions between Levonorgestrel Vaginal Delivery System and Miconazole in Healthy Female Subjects	Portugal	Not Recruiting
Evaluation of Pharmacokinetic Interactions between Levonorgestrel Vaginal Delivery System and Tampons and Lubricants in Healthy Female Subjects	Portugal	Not Recruiting
Evaluation of the Impact of LF111 and Drospirenone on Bone Mineral Density in Adolescent and Adult Females Using Hormonal Contraceptives	Czechia Poland	Not Recruiting
Phase 1 Study to Evaluate the Pharmacokinetics and Safety of Three Testosterone Gel Formulations in Postmenopausal Women	Spain	Not Recruiting